MLN antibody

Principal name

MLN antibody

Alternative names for MLN antibody

Promotilin, Motilin, MAP, Motilin-associated peptide

SwissProt ID

O18845 (Sheep), O62820 (Bovin), P01307 (Pig), P12872 (Human), Q9PRP6 (Chick)

Gene ID

4295 (MLN)

Available reactivities

Hu (Human), Sh (Sheep)

Available hosts

Rabbit, Mouse

Available applications

Western blot / Immunoblot (WB), Enzyme Immunoassay (E)

Background of MLN antibody

Kit Component:
- KN221639G1, MLN gRNA vector 1 in pCas-Guide vector
- KN221639G2, MLN gRNA vector 2 in pCas-Guide vector
- KN221639D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

16 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

MLN antibody

WB Suggested Anti-MLN Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: HT1080 cell lysate Rabbit IgG Purified Hu, Sh WB
50 µg / €325.00
  OriGene Technologies, Inc.

MLN antibody

MLN Mouse IgG2a 4E12 Purified Hu E, WB
0.1 mg / €370.00
  Abnova Taiwan Corp.

MLN antibody

Human HT1080; WB Suggested Anti-MLN Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: HT1080 cell lysate; MLN antibody - middle region (ARP44916_P050) in Human HT1080 cells using Western Blot Rabbit Aff - Purified Hu WB
50 µg / €350.00
  AVIVA Systems Biology

CRISPR

Catalog No. Species Donor Vector  

MLN - human gene knockout kit via CRISPR

MLN - human gene knockout kit via CRISPR Human GFP-Puro
1 kit / €1,200.00
  OriGene Technologies, Inc.

MLN - human gene knockout kit via CRISPR

MLN - human gene knockout kit via CRISPR Human mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

MLN - human gene knockout kit via CRISPR

MLN - human gene knockout kit via CRISPR Human Luciferase-Puro
1 kit / €1,290.00
  OriGene Technologies, Inc.

MLN - human gene knockout kit via CRISPR

MLN - human gene knockout kit via CRISPR Human RFP-BSD
1 kit / €1,290.00
  OriGene Technologies, Inc.

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

MLN (transcript variant 1)

MLN Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

MLN (transcript variant 2)

MLN Human > 95 %
Preparation: .
Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
10 µg / €139.00
  OriGene Technologies, Inc.

MLN

MLN Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
10 µg / €380.00
  Abnova Taiwan Corp.

MLN

MLN Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
25 µg / €510.00
  Abnova Taiwan Corp.

Lysates

Catalog No.    

MLN overexpression lysate

MLN overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, MLN (mGFP-tagged)-Human motilin (MLN), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, MLN (mGFP-tagged)-Human motilin (MLN), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, MLN (mGFP-tagged)-Human motilin (MLN), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, MLN (mGFP-tagged)-Human motilin (MLN), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €880.00
  OriGene Technologies, Inc.

Lenti ORF particles, MLN (Myc-DDK-tagged)-Human motilin (MLN), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, MLN (Myc-DDK-tagged)-Human motilin (MLN), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

Lenti ORF particles, MLN (Myc-DDK-tagged)-Human motilin (MLN), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, MLN (Myc-DDK-tagged)-Human motilin (MLN), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €780.00
  OriGene Technologies, Inc.

16 Item(s)

per page
  • LinkedIn